Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Artificial Intelligence
MedTech
Industry at a ‘turning point’ with growth dominated by leaders
In 2025 through the first half of 2026, innovation increased dealmaking and R&D investment as AI heavily influenced the future of value creation.
Patrick McGuire
Oct 20, 2026 7:43am
AstraZeneca, insitro ink $1.5B AI-enabled target discovery deal
Oct 15, 2026 6:00am
GSK drinks in Chai’s AI models after wet-lab validation
Oct 9, 2026 10:36am
UK unveils new policy to constantly monitor AI-based devices
Oct 6, 2026 8:02am
NIH debuts tool to help scientists navigate biomedical database
Sep 24, 2026 2:00pm
Iambic maintains momentum from Big Pharma collabs with IPO plans
Sep 22, 2026 3:14am
